Start an analysis for MLAB
Mesa Laboratories Inc
Stock · NASDAQProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $80mEST | 30-Sep-26 | 10-Q filed 09-Nov-26 |
| Remaining authorization | $62mEST | 30-Sep-26 | 10-Q filed 09-Nov-26 |
| Program expiry | 31-Dec-28 | 30-Sep-26 | 10-Q filed 09-Nov-26 |
| Repurchased last quarter | $0 | 30-Sep-26 | 10-Q filed 09-Nov-26 |
| Has used an ASR | No | — |
Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 04-Nov-26 | $40m | $40mEST | 31-Dec-28 | On November 4, 2026, the Board of Directors terminated the Company’s existing share repurchase program, which was authorized in 2005, and authorized a new program to repurchase up to $40.0 million of the Company’s common stock.10-Q filed 09-Nov-26 |
| 07-Nov-05 | $40mEST 300,000 sh | $22mEST 162,486 sh left | n/a | Board of Directors adopted a share repurchase plan which allows for the repurchase of up to 300,000 of our common shares; however, no shares have been purchased under the plan in any period presented herein. This plan will continue until the maximum is reached or the plan is terminated by further action of the Board of Directors.10-Q filed 09-Nov-26 |
Open-market repurchases
- Apr ’26
- May ’26
- Jun ’26
- Jul ’26
- Aug ’26
- Sep ’26
| Month ended | Shares | Withheld & other | Avg price | ≈ Value | Source |
|---|---|---|---|---|---|
| 30-Sep-26 | 0 | — | — | $0 | 10-Q filed 09-Nov-26 |
| 31-Aug-26 | 0 | — | — | $0 | 10-Q filed 09-Nov-26 |
| 31-Jul-26 | 0 | — | — | $0 | 10-Q filed 09-Nov-26 |
| 30-Jun-26 | 10,125 | 10,125 | $94.65 | $958.3k | 10-Q filed 10-Aug-26 |